Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
norUDCA Dose-Finding in PSC
NCT01755507Phase 2Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Dec 2012
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of norursodeoxycholic acid in Primary Sclerosing Cholangitis (PSC), sponsored by Dr. Falk Pharma GmbH. Started Dec 2012; status: completed.
02
Drugs
norursodeoxycholic acid
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT01755507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755507.